LAUNCH OF THE GAVI 2015 APPLICATION ROUND FOR NEW VACCINES AND HEALTH SYSTEM STRENGHTENING SUPPORT

GAVI has opened its 2015 round of applications for new vaccines, including the HPV vaccine, as well as health system strengthening support.

GAVI SUPPORT FOR THE PROMOTION OF ACCESS TO THE HPV VACCINE

In 2012, GAVI invited eligible countries to apply for support to introduce HPV vaccines into their routine immunisation programmes. With the first vaccine introductions starting in 2014, HPV vaccines will provide tens of millions of girls with a future free of the threat of cervical cancer. Countries can apply through one of two pathways: Funding proposals for nationwide introduction will need to demonstrate the country’s ability to successfully deliver vaccines to 9–13 year-old girls; countries lacking experience can apply for support for two-year demonstration projects that will allow them to learn by doing before applying for national introduction.

To learn more about GAVI support with regards to prevention of cancers, consult the GAVI webpage on the HPV vaccine support or download the GAVI fact sheet: HPV. GAVI and UICC have also recently issued a fact sheet on the importance of vaccines – HPV and HBV – for preventing cancers: GAVI/UICC fact sheet: Revolutionising cancer prevention with vaccines

Access additional materials about GAVI actions and HPV vaccine in the ICCP library of resources

gavi 2015 APPLICATION PROCESS AND REVIEW TIMELINES

Applications for both New Vaccine Support (NVS) and Health System Strengthening (HSS) will now be accepted through the same application and review timelines. The General Guidelines for Expressions of Interest for All Types of Gavi Support 2015 document offers an introduction to the principles, policies and processes that are applicable to all types of GAVI support.

Supplementary vaccine-specific guidance is included in the application materials. These guidelines provide important details on the application process, requirements and key considerations specific to each type of Gavi supported vaccine. The guidelines have been updated to include vaccine-specific changes including requirements for campaigns where applicable. The Supplementary HSS Guidelines provide step-by-step guidance on applying for cash based support from Gavi.

As outlined in the timelines table below, countries are not required to submit an Expression of Interest for the January window in 2015. Please note, country applications will be accepted on a rolling basis, so if a country misses a cut-off date, the application will be reviewed by the subsequent Independent Review Committee (IRC).

Application & Review Timelines for 2015

2015

Latest date for submission of Expression of Interest*

Latest date for submission of Application

Application review dates (Independent Review Committee)

Gavi CEO or Executive Committee/Board decision
New requests, for any type of Gavi support Not applicable 25 January 2015 16-27 March 2015 June 2015
New requests, for any type of Gavi support (excluding IPV) 8 May 2015 8 September 2015 6-20 November 2015 Early March 2016

*The EOI is not required for IPV applications due to the accelerated timelines of the polio eradication Endgame Plan. 

GAVI Application materials in 2015 :

General Guidelines for Expressions of Interest and Applications for All Types of GAVI Support in 2015

SUPPLEMENTARY VACCINE SPECIFIC GUIDELINES:

HPV Vaccine:

Human Papillomavirus vaccine support for national introductioni guidelines

Application materials for HPV Demonstration Programme:

HPV demo application guidelines

HPV demo application form (forthcoming)

HPV demo chronogram template (forthcoming)

HPV demo budget and financing template (forthcoming)

All supplementary guidelines, application forms, and more information and resources about this year’s application process can be found on GAVI website at http://www.gavi.org/support/apply/